左旋布诺洛尔和美替洛尔：眼压降低效果、安全性及舒适度的比较
Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort.
作者信息
Krieglstein G K, Novack G D, Voepel E, Schwarzbach G, Lange U, Schunck K P, Lue J C, Glavinos E P
出版信息
Br J Ophthalmol. 1987 Apr;71(4):250-3. doi: 10.1136/bjo.71.4.250.
Abstract
Topical levobunolol 0.5% was compared with topical metipranolol 0.6% for efficacy, safety, and comfort in 46 patients with open angle glaucoma or ocular hypertension. The study was of parallel design, randomised, double-masked, and of three months' duration. After a washout interval the study medications were instilled twice daily in both eyes. The overall mean decrease in intraocular pressure (IOP) was approximately 7 mmHg in both groups. More than 90% of patients in both groups successfully completed the study. Both agents caused slight decreases in heart rate and blood pressure. More complaints of burning and stinging were reported in the metipranolol group than in the levobunolol group. This three-month, 46-patient study showed levobunolol 0.5% and metipranolol 0.6% to be similarly effective ocular hypotensive agents.
摘要
在46例开角型青光眼或高眼压症患者中，对0.5%的噻吗洛尔滴眼液与0.6%的美替洛尔滴眼液的疗效、安全性及舒适度进行了比较。该研究采用平行设计、随机、双盲，为期3个月。经过洗脱期后，研究药物每天双眼各滴入两次。两组的眼内压（IOP）总体平均下降约7 mmHg。两组均有超过90%的患者成功完成了研究。两种药物均导致心率和血压略有下降。美替洛尔组报告的烧灼感和刺痛感比噻吗洛尔组更多。这项为期3个月、涉及46名患者的研究表明，0.5%的噻吗洛尔和0.6%的美替洛尔是同样有效的降眼压药物。
相似文献
1
Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort.左旋布诺洛尔和美替洛尔：眼压降低效果、安全性及舒适度的比较
Br J Ophthalmol. 1987 Apr;71(4):250-3. doi: 10.1136/bjo.71.4.250.
2
[Local subjective tolerance of levobunolol and metipranolol in a double-blind comparative study in patients with increased intraocular pressure].[左旋布诺洛尔和美替洛尔在眼压升高患者中的双盲对照研究中的局部主观耐受性]
Ophthalmologica. 1986;192(3):159-64. doi: 10.1159/000309631.
3
Efficacy and safety of once-daily levobunolol for glaucoma therapy.
Can J Ophthalmol. 1989 Feb;24(1):2-6.
4
A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatment.
Ophthalmology. 1989 Jan;96(1):8-11. doi: 10.1016/s0161-6420(89)32940-x.
5
Long-term ocular hypotensive effect of levobunolol: results of a one-year study.左旋布诺洛尔的长期眼压降低作用：一项为期一年的研究结果。
Br J Ophthalmol. 1985 Aug;69(8):593-9. doi: 10.1136/bjo.69.8.593.
6
Levobunolol. A three-month efficacy study in the treatment of glaucoma and ocular hypertension.
Arch Ophthalmol. 1985 Mar;103(3):375-8. doi: 10.1001/archopht.1985.01050030071024.
7
Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.每日两次使用左布诺洛尔治疗眼压升高的疗效。
Can J Ophthalmol. 1988 Jun;23(4):168-70.
8
Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
Ophthalmology. 1989 May;96(5):642-5.
9
[Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma].[左旋布诺洛尔与噻吗洛尔治疗高眼压症和慢性开角型青光眼的有效性和安全性比较]
Klin Monbl Augenheilkd. 1988 Sep;193(3):257-60. doi: 10.1055/s-2008-1050254.
10
Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure.左布诺洛尔和倍他洛尔。眼压升高患者疗效与安全性的双盲对照比较。
Ophthalmology. 1988 Jun;95(6):735-41. doi: 10.1016/s0161-6420(88)33123-4.
引用本文的文献
1
Metipranolol promotes structure and function of retinal photoreceptors in the rd10 mouse model of human retinitis pigmentosa.美替洛尔促进 rd10 人视网膜色素变性小鼠模型中视网膜光感受器的结构和功能。
J Neurochem. 2019 Jan;148(2):307-318. doi: 10.1111/jnc.14613. Epub 2018 Dec 3.
2
Management of glaucoma: focus on pharmacological therapy.青光眼的治疗：聚焦于药物治疗。
Drugs Aging. 2005;22(1):1-21. doi: 10.2165/00002512-200522010-00001.
3
Incidence of ocular side effects of topical beta blockers in the Netherlands.荷兰局部用β受体阻滞剂眼部副作用的发生率。
Br J Ophthalmol. 2000 Aug;84(8):856-9. doi: 10.1136/bjo.84.8.856.
4
Pharmacological therapy for glaucoma: a review.青光眼的药物治疗：综述
Drugs. 2000 Mar;59(3):411-34. doi: 10.2165/00003495-200059030-00003.
5
Acute effect of metipranolol on the retinal circulation.美替洛尔对视网膜循环的急性作用。
Br J Ophthalmol. 1998 Aug;82(8):892-6. doi: 10.1136/bjo.82.8.892.
6
Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.眼部用美替洛尔。其药效学和药代动力学特性以及在青光眼和高眼压症治疗效果的初步综述。
Drugs. 1988 Nov;36(5):601-15. doi: 10.2165/00003495-198836050-00004.
7
Topically applied levobunolol does not cause changes in the corneal endothelium.局部应用的左布诺洛尔不会引起角膜内皮的变化。
Doc Ophthalmol. 1990;76(3):273-7. doi: 10.1007/BF00142686.
8
Metipranolol-associated granulomatous anterior uveitis.美替洛尔相关的肉芽肿性前葡萄膜炎。
Br J Ophthalmol. 1991 Sep;75(9):519-23. doi: 10.1136/bjo.75.9.519.
9
Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.青光眼治疗中的眼部β受体阻滞剂。临床药理学方面。
Drugs Aging. 1992 May-Jun;2(3):208-21. doi: 10.2165/00002512-199202030-00005.
本文引用的文献
1
A clinical evaluation of the effects of topically applied levobunolol and timolol on increased intraocular pressure.
Am J Ophthalmol. 1982 Sep;94(3):318-27. doi: 10.1016/0002-9394(82)90357-9.
2
A dose-response study of the effect of levobunolol on ocular hypertension.左旋布诺洛尔对高眼压症影响的剂量反应研究。
Am J Ophthalmol. 1983 Feb;95(2):229-32. doi: 10.1016/0002-9394(83)90018-1.
3
Ocular beta-blockers and systemic effects.眼部β受体阻滞剂及其全身效应。
Am J Ophthalmol. 1984 Nov;98(5):623-4. doi: 10.1016/0002-9394(84)90250-2.
4
Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.局部用倍他洛尔、噻吗洛尔及安慰剂对哮喘性支气管炎肺功能的影响。
Am J Ophthalmol. 1984 Jan;97(1):86-92. doi: 10.1016/0002-9394(84)90450-1.
5
[Metipranolol--a new beta-blocker].美替洛尔——一种新型β受体阻滞剂
Klin Monbl Augenheilkd. 1983 Jun;182(6):582-4. doi: 10.1055/s-2008-1054859.
6
Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.局部用倍他洛尔、噻吗洛尔及安慰剂对哮喘性支气管炎肺功能的影响。
Am J Ophthalmol. 1985 Sep 15;100(3):492-4. doi: 10.1016/0002-9394(85)90532-x.
7
[Local subjective tolerance of levobunolol and metipranolol in a double-blind comparative study in patients with increased intraocular pressure].[左旋布诺洛尔和美替洛尔在眼压升高患者中的双盲对照研究中的局部主观耐受性]
Ophthalmologica. 1986;192(3):159-64. doi: 10.1159/000309631.
8
A blind randomised cross-over trial comparing metipranolol 0.3% with timolol 0.25% in open-angle glaucoma: a pilot study.一项在开角型青光眼中比较0.3%美替洛尔与0.25%噻吗洛尔的盲法随机交叉试验：一项试点研究。
Br J Ophthalmol. 1986 Jan;70(1):39-42. doi: 10.1136/bjo.70.1.39.
Zotero 插件